Jean-Christophe Marine has made significant contributions to melanoma biology, especially in the study of therapy resistance. His most notable discovery is the identification of a TCF4-dependent gene regulatory network that drives cross-resistance to both immune checkpoint blockade and targeted therapies. His work has also advanced the understanding of tumor plasticity and cellular hierarchy in melanoma, paving the way for combinatorial treatment strategies and addressing tumor progression and immune evasion.
